Tumor-Induced Osteomalacia Presenting as Bilateral Intertrochanteric Fractures: A Rare Case Report
DOI:
https://doi.org/10.64917/fmcs-005Keywords:
Tumor-induced osteomalacia, bilateral intertrochanteric fractures, hypophosphatemia, phosphaturic mesenchymal tumorAbstract
Background: Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome characterized by phosphate wasting, leading to hypophosphatemia, bone pain, and fractures. Its nonspecific symptoms often delay diagnosis, complicating management.
Case Presentation: We report a rare case of a middle-aged patient presenting with bilateral intertrochanteric femur fractures without significant trauma. Biochemical evaluation revealed hypophosphatemia, elevated alkaline phosphatase, and low vitamin D levels. Further investigations identified a phosphaturic mesenchymal tumor responsible for TIO. Surgical excision of the tumor resulted in normalization of phosphate levels and clinical improvement.
Conclusion: This case highlights the importance of considering TIO in patients with unexplained fractures and metabolic bone disease. Early diagnosis and tumor localization are critical for effective treatment and prevention of further skeletal complications.
References
Yu WJ, He JW, Fu WZ, Wang C, Zhang ZL. J Bone Miner Metab. 2017 May;35(3):298-307. doi: 10.1007/s00774-016-0756-9. Epub 2016 Apr 16. PMID: 27085966.
Hu FK, Yuan F, Jiang CY, Lv DW, Mao BB, Zhang Q, Yuan ZQ, Wang Y. Chin J Cancer. 2011 Nov;30(11):794-804. doi: 10.5732/cjc.011.10013. PMID: 22035861.
Tungenwar S, Subith S, Mukadam M, Kokate S, Gunay S. Phosphaturic Mesenchymal Tumor in the Proximal Femur Presenting as Tumor-induced Osteomalacia: A Case Report and Literature Review. J Orthop Case Rep. 2024 Feb;14(2):120-123.
Insogna KL. Tumor-Induced Osteomalacia. Endocr Rev. 2016 Apr;37(2):166-77. doi: 10.1210/er.2015-1104.
Feng J, et al. Diagnosis and Management of Tumor-Induced Osteomalacia: A Multidisciplinary Approach. J Clin Endocrinol Metab. 2020 Sep 1;105(9):dgaa356. doi: 10.1210/jcem/dgaa356.
Zhang ZL, et al. Consensus on clinical management of tumor-induced osteomalacia. Endocrine. 2020 Oct;69(1):1-10. doi: 10.1007/s12020-020-02390-3.
Minisola S, et al. Tumor-induced osteomalacia: A comprehensive review. Endocr Rev. 2023 Mar 4;44(2):323-353. doi: 10.1210/endrev/bnac026.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dr. Ananya Sharma, MD, Dr. Rajesh Kumar Singh, MD

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their articles published in this journal. All articles are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited.